No Data
No Data
Just the Facts: Recce Pharmaceuticals Completes Dosing in RECCE 327 Phase 2 Trial | ASX:RCE, OTC:RECEF
'Significant' New Milestone for Recce in Clinical Testing of Skin Infection Gel
Recce Pharmaceuticals Completes Dosing Patients for Phase Two Wound Infection Trial
Recce Pharmaceuticals Secures Approval for Diabetic Food Infection Clinical Trial in Indonesia; Shares Rise 5%
Recce Pharmaceuticals Advances Phase 3 Trial in Indonesia
Recce Pharmaceuticals Ready for Phase 3 Clinical Trial of R327G in Diabetic Foot Infections in Indonesia | ASX:RCE, OTC:RECEF